Wellmune WGP and Active Yogurt Cultures Provide Synergistic Immune Support in New Drinkable Yogurt
Wellmune WGP, the clinically proven natural immune health ingredient from Biothera, is now available in a drinkable yogurt product from Grupo Gloria, the largest commercial dairy company in Peru. Initial distribution is planned to retail locations across the country including supermarkets and convenience stores.
15 Jan 2013 --- Gloria’s Pro Defensis marries the clinically proven systemic immune health benefits of Wellmune WGP with the gut health benefits of probiotics. It is the first-ever yogurt to combine these clinically proven benefits.
“Yogurt is an everyday, mainstream food product making it an ideal delivery system for the daily immune support that Wellmune WGP provides,” said Richard Mueller, CEO, Biothera. “We’re gratified that working closely with Gloria and our distributor Quimtia, yogurt now joins the wide range of applications for the proven immune health benefits of Wellmune WGP.”
Pro Defensis is available in vanilla and strawberry flavors. Each bottle delivers 100 mg ofWellmune. The recommended daily serving is 2.5 mg/kilo of body weight.
Wellmune WGP is a proprietary baker’s yeast beta 1,3/1,6 glucan that is clinically proven to prime key immune cells that keep the body healthy. This natural food, beverage and supplement ingredient has regulatory approval around the world, including GRAS status in the U.S. and novel foods approval in Europe and China. Wellmune is available in more than 100 products in more than 50 countries around the world. It is also patented, Kosher, Halal, non-allergenic and GMO-free. In addition to receiving an IFT Innovation Award, Wellmune has received a SupplySide West Scientific Excellence Award and a Frost & Sullivan Excellence in Research Award. Wellmune WGP is a product of Biothera, a U.S. biotechnology company dedicated to improving immune health.
To contact our editorial team please email us at editorial@cnsmedia.com
If you found this article valuable, you may wish to receive our newsletters.
Subscribe now to receive the latest news directly into your inbox.
Subscribe now to receive the latest news directly into your inbox.
.jpg)
